Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Drafting Analytical Specifications – V 2.0

Posted on By

Analytical Method Development: Drafting Analytical Specifications – V 2.0

SOP for Drafting Analytical Specifications in Method Development


Department Analytical Method Development
SOP No. SOP/AMD/020/2025
Supersedes SOP/AMD/020/2022
Page No. Page 1 of 15
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

The purpose of this SOP is to outline the systematic procedure for drafting analytical specifications for raw materials, intermediates, drug substances, and finished pharmaceutical products. It ensures specifications are scientifically justified, aligned with regulatory

requirements (ICH Q6A/B), and support product quality throughout its lifecycle.

2. Scope

This SOP applies to personnel involved in the creation, review, and approval of analytical specifications within the Analytical Method Development (AMD), Quality Control (QC), Quality Assurance (QA), and Regulatory Affairs departments.

3. Responsibilities

  • Analytical Scientist: Drafts the analytical specifications in consultation with the product development team and based on method capabilities.
  • Team Lead: Reviews and approves specification rationales and technical suitability.
  • QA: Ensures specifications meet regulatory and pharmacopoeial standards and are clearly defined.
  • Regulatory Affairs: Ensures alignment with filing requirements and global market expectations.
  • Head – AMD: Provides final approval for use and submission.
See also  Analytical Method Development: Method Optimization Protocol - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring all analytical specifications are technically sound, regulatory-compliant, and approved before implementation in validation and routine use.

5. Procedure

5.1 Specification Initiation

  1. Initiate specification drafting at the completion of method development and prior to validation.
  2. Assign Specification Code in format: SPEC/[Material Type]/[Product Code]/[Version]
  3. Record in Annexure-1: Specification Register.

5.2 Components of a Specification Sheet

  1. The specification document shall include the following sections:
    • Material Name and Code
    • Specification Type (e.g., API, finished product, excipient)
    • Test Parameters
    • Test Method (Pharmacopoeial / Non-Pharmacopoeial)
    • Acceptance Criteria
    • Reference Documents
  2. Use the format defined in Annexure-2: Specification Template.

5.3 Selection and Justification of Tests

  1. Include tests based on material type and risk assessment:
    • Identity
    • Assay
    • Impurities/Degradants
    • Residual solvents
    • Water content
    • Microbiological tests
  2. Reference pharmacopoeias (e.g., IP, USP, BP, Ph. Eur.) and ICH Q6A/B as applicable.
  3. Document justification in Annexure-3: Specification Justification Record.
See also  Analytical Method Development: Method Feasibility Evaluation - V 2.0

5.4 Specification Limits

  1. Set acceptance criteria based on:
    • Pharmacopoeial monographs
    • Clinical safety margins
    • Manufacturing process capability
    • Regulatory precedent
  2. Ensure numerical limits include appropriate units and decimal precision.

5.5 Specification Review and Approval

  1. Submit draft to QA, Regulatory Affairs, and Product Development for review.
  2. Compile comments and finalize the specification sheet.
  3. Approval from Head – AMD and QA Head is mandatory.
  4. Record approval history in Annexure-4: Specification Approval Log.

5.6 Specification Revisions and Control

  1. Trigger revisions in the event of:
    • Change in method
    • Change in product composition
    • New regulatory requirement
    • OOS investigation conclusions
  2. Assign new version numbers and archive obsolete specifications.

6. Abbreviations

  • AMD: Analytical Method Development
  • QC: Quality Control
  • QA: Quality Assurance
  • OOS: Out of Specification
  • USP: United States Pharmacopeia
  • IP: Indian Pharmacopoeia
  • ICH: International Council for Harmonisation

7. Documents

  1. Specification Register – Annexure-1
  2. Specification Template – Annexure-2
  3. Specification Justification Record – Annexure-3
  4. Specification Approval Log – Annexure-4
See also  Analytical Method Development: Technology Transfer of Analytical Methods - V 2.0

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • ICH Q6B – Specifications for Biotechnological Products
  • ICH Q14 – Analytical Procedure Development
  • WHO TRS 996 – Annex 3

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Specification Register

Spec Code Material Name Type Version Status
SPEC/API/AMLO/001 Amlodipine Besylate API 1.0 Active

Annexure-2: Specification Template

Test Method Acceptance Criteria
Identification (IR) Ph. Eur. Conforms
Assay HPLC 98.5% – 101.5%
Related Substances HPLC Total ≤ 1.0%

Annexure-3: Specification Justification Record

Test Justification
Water Content Required due to hygroscopic nature of API

Annexure-4: Specification Approval Log

Version Date Prepared By Reviewed By Approved By
1.0 18/05/2025 Sunita Reddy Rajesh Kumar Dr. Vinay Pawar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added justification and control revision sections ICH Q6A alignment
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Cell Culture Media Optimization – V 2.0
Next Post: Elixir Department: SOP for Control and Use of Primary Containers During Dispensing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version